Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients

Parkinsonism and Related Disorders

Volumn 18, Issue 1, 2012, Pages 59-62

  Brusa, Livia ^a   Ceravolo, Roberto ^b   Kiferle, Lorenzo ^b   Monteleone, Fabrizia ^c   Iani, Cesare ^a   Schillaci, Orazio ^c,d   Stanzione, Paolo ^e,f   Koch, Giacomo ^e,f  

^a S EUGENIO HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS NEUROMED   (Italy)

^e TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^f IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cerebellum; Dyskinesias; Levodopa; Parkinson's disease; TMS

Indexed keywords

AMANTADINE; ENTACAPONE; FLUORODEOXYGLUCOSE F 18; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; TOLCAPONE;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTINUOUS PROCESS; CONTROLLED STUDY; DENTATE NUCLEUS; DRUG SAFETY; DYSKINESIA; FEMALE; HEMISPHERE; HUMAN; MALE; NERVE CELL NETWORK; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPEAT PROCEDURE; THETA BURST STIMULATION; THETA RHYTHM; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; CEREBELLUM; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NERVE NET; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; THETA RHYTHM; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84655169157     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.08.019     Document Type: Article

References (33)

1. Marsden C.D., Parkes J.D., Quinn N. Fluctuations of disability in Parkinson's disease-clinical aspects. Movement disorders III 1994, 180-199. Butterworth-Heinemann, Oxford. C.D. Marsden, S. Fahn (Eds.).
2. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol 2000, 47:2-9.
3. Koch G., Brusa L., Caltagirone C., Peppe A., Oliveri M., Stanzione P., et al. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology 2005, 65:623-625.
4. Brusa L., Versace V., Koch G., Iani C., Stanzione P., Bernardi G., et al. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clin Neurophysiol 2006, 117:1917-1921.
5. Wagle-Shukla A., Angel M.J., Zadikoff C., Enjati M., Gunraj C., Lang A.E., et al. Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 2007, 68:704-705.
6. Filipović S.R., Rothwell J.C., van de Warrenburg B.P., Bhatia K. Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease. Clin Neurophysiol 2010, 121:1129-1137.
7. Rektorova I., Sedlackova S., Telecka S., Hlubocky A., Rektor I. Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulation. Int J Biomed Imaging 2008, 2008:372125.
8. Starr P.A., Vitek J.L., Bakay R.A. Ablative surgery and deep brain stimulation for Parkinson's disease. Neurosurgery 1998, 43:989-1015.
9. Lang A.E. Surgery for levodopa-induced dyskinesias. Ann Neurol 2000, 47(4 Suppl. 1):S193-S199. discussion S199-202.
10. Fukuda M., Mentis M.J., Ma Y., Dhawan V., Antonini A., Lang A.E., et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain 2001, 124:1601-1609.
11. Nimura T., Ando T., Yamaguchi K., Nakajima T., Shirane R., Itoh M., et al. The role of sigma-receptors in levodopa-induced dyskinesia in patients with advanced Parkinson disease: a positron emission tomography study. JNeurosurg 2004, 100:606-610.
12. Koch G., Brusa L., Carrillo F., Lo Gerfo E., Torriero S., Oliveri M., et al. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology 2009, 73:113-119.
13. Oliveri M., Koch G., Torriero S., Caltagirone C. Increased facilitation of the primary motor cortex following 1 Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans. Neurosci Lett 2005, 376:188-193.
14. Koch G., Mori F., Marconi B., Codecà C., Pecchioli C., Salerno S., et al. Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum. Clin Neurophysiol 2008, 119:2559-2569.
15. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
16. Defer G.L., Widner H., Marié R.M., Rémy P., Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999, 14:572-584.
17. Huang Y.Z., Edwards M.J., Rounis E., Bhatia K.P., Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron 2005, 45:201-206.
18. Koch G., Oliveri M., Torriero S., Salerno S., Lo Gerfo E., Caltagirone C. Repetitive TMS of cerebellum interferes with millisecond time processing. Exp Brain Res 2007, 179:291-299.
19. Del Olmo M.F., Cheeran B., Koch G., Rothwell J.C. Role of the cerebellum in externally paced rhythmic finger movements. JNeurophysiol 2007, 98:145-152.
20. Ugawa Y., Uesaka Y., Terao Y., Hanajima R., Kanazawa I. Magnetic stimulation over the cerebellum in humans. Ann Neurol 1995, 37:703-713.
21. Tofts P.S. The distribution of induced currents in magnetic stimulation of the nervous system. Phys Med Biol 1990, 35(8):1119-1128.
22. Koch G. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets. Restor Neurol Neurosci 2010, 28(4):561-568.
23. Rothwell J.C. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. JNeurosci Methods 1997, 74:113-122.
24. Wassermann E.M., Lisanby S.H. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001, 112(8):1367-1377.
25. Strafella A., Ashby P., Lang A.E. Pallidotomy increases cortical inhibition in Parkinson's disease. Can J Neurol Sci 1997, 24:133-136.
26. Ceravolo R., Borghetti D., Kiferle L., Tognoni G., Giorgetti A., Neglia D., et al. CSF phosphorylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Res Bull 2008, 76:80-84.
27. Reis J., Swayne O.B., Vandermeeren Y., Camus M., Dimyan M.A., Harris-Love M., et al. Contribution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control. JPhysiol 2008, 586:325-351.
28. Centonze D., Bernardi G., Koch G. Mechanisms of disease: basic-research-driven investigations in humans - the case of hyperkinetic disorders. Nat Clin Pract Neurol 2007, 3:572-580.
29. Ito M. Control of mental activities by internal models in the cerebellum. Nat Rev Neurosci 2008, 9:304-313.
30. Brooks D.J., Piccini P., Turjanski N., Samuel M. Neuroimaging of dyskinesia. [Review]. Ann Neurol 2000, 47:S154-S158.
31. Rascol O., Sabatini U., Brefel C., Fabre N., Rai S., Senard J.M., et al. Cortical motor overactivation in parkinsonian patients with levodopa-induced peak-dose dyskinesia. Brain 1998, 121:527-533.
32. Bezard E., Brotchie J.M., Gross C.E. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2001, 2:577-588.
33. Strafella A.P., Paus T., Fraraccio M., Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003 Dec, 126(Pt 12):2609-2615.